Qiagen N.V. | Large-cap | Healthcare
$48.64
0.89%
| Qiagen N.V Stock Comparison:
Qiagen N.V vs Thermo FisherQiagen N.V vs DanaherQiagen N.V vs Medpace HoldingsQiagen N.V vs Charles RiverQiagen N.V vs Guardant HealthQiagen N.V vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 2.0B
Gross Profit 967.4M 48.90%
Operating Income 199.9M 10.11%
Net Income 83.6M 4.23%
EPS (Diluted) $0.38

Balance Sheet Metrics

Total Assets 5.7B
Total Liabilities 2.1B
Shareholders Equity 3.6B
Debt to Equity 0.59

Cash Flow Metrics

Operating Cash Flow 464.1M
Free Cash Flow 502.3M

Revenue & Profitability Trend

Qiagen N.V Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 2.0B 2.0B 2.1B 2.3B 1.9B
Cost of Goods Sold 1.0B 731.6M 757.0M 800.8M 637.6M
Gross Profit 967.4M 1.2B 1.4B 1.5B 1.2B
Operating Expenses 757.9M 777.7M 793.8M 774.4M 674.4M
Operating Income 199.9M 445.2M 576.2M 657.8M 537.5M
Pre-tax Income 121.1M 429.8M 512.6M 625.8M 439.5M
Income Tax 37.6M 88.5M 89.4M 113.2M 80.3M
Net Income 83.6M 341.3M 423.2M 512.6M 359.2M
EPS (Diluted) $0.38 $1.53 $1.90 $2.28 $0.32

Income Statement Trend

Qiagen N.V Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 2.0B 2.1B 2.4B 2.1B 1.6B
Non-Current Assets 3.7B 4.0B 3.9B 4.0B 4.2B
Total Assets 5.7B 6.1B 6.3B 6.1B 5.9B
Liabilities
Current Liabilities 543.6M 1.1B 974.5M 1.5B 572.2M
Non-Current Liabilities 1.6B 1.2B 1.8B 1.5B 2.5B
Total Liabilities 2.1B 2.3B 2.8B 3.1B 3.1B
Equity
Total Shareholders Equity 3.6B 3.8B 3.5B 3.1B 2.8B

Balance Sheet Composition

Qiagen N.V Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 83.6M 341.3M 423.2M 512.6M 359.2M
Operating Cash Flow 464.1M 506.5M 654.9M 726.3M 601.3M
Investing Activities
Capital Expenditures -167.2M -149.7M -129.2M -189.9M -132.8M
Investing Cash Flow -245.2M -74.6M -706.7M -185.8M -271.8M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -422.9M -470.6M -125.8M -150.4M -174.0M
Free Cash Flow 502.3M 296.7M 565.9M 432.5M 153.6M

Cash Flow Trend

Qiagen N.V Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 108.63
Forward P/E 20.40
Price to Book 2.97
Price to Sales 5.05
PEG Ratio 20.40

Profitability Ratios

Profit Margin 4.68%
Operating Margin 25.89%
Return on Equity 2.67%
Return on Assets 5.75%

Financial Health

Current Ratio 3.37
Debt to Equity 41.36
Beta 0.67

Per Share Data

EPS (TTM) $0.43
Book Value per Share $15.74
Revenue per Share $9.25

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
qgen 10.1B 108.63 2.97 2.67% 4.68% 41.36
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Medpace Holdings 8.9B 23.58 15.48 65.83% 19.31% 25.33
Charles River 7.2B 681.33 2.27 -0.67% -0.49% 92.21
Guardant Health 6.0B -14.19 -24.95 312.48% -53.82% -5.21

Financial data is updated regularly. All figures are in the company's reporting currency.